Conversion from latent to symptomatic Sheehan's syndrome by pegylated interferon therapy for chronic hepatitis C

Internal Medicine

Volumn 47, Issue 10, 2008, Pages 939-941

  Kanda, Keitaro ^a,b   Kayahara, Takahisa ^b   Seno, Hiroshi ^a   Yamashita, Yukitaka ^b   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Endocrine abnormality; Hypopituitarism; Obstetric hemorrhage

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; PEGINTERFERON ALPHA2A; PROLACTIN; PROTIRELIN; THYROID HORMONE; ALPHA2A INTERFERON; ANTIVIRUS AGENT; HORMONE; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; THYROXINE;

ADENOHYPOPHYSIS DISEASE; ADULT; ANAMNESIS; ARTICLE; BLOOD EXAMINATION; BLOOD TRANSFUSION; CASE REPORT; DISEASE SEVERITY; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPONATREMIA; HYPOPITUITARISM; HYPOTHYROIDISM; MALAISE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRIC HEMORRHAGE; PROLACTIN BLOOD LEVEL; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POSTPARTUM HEMORRHAGE; TIME;

ADRENOCORTICOTROPIC HORMONE; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HORMONES; HUMANS; HYPOPITUITARISM; INTERFERON ALFA-2A; MIDDLE AGED; POLYETHYLENE GLYCOLS; POSTPARTUM HEMORRHAGE; THYROXINE; TIME FACTORS;

EID: 45849154211     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0990     Document Type: Article

References (11)

1. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia. J Clin Oncol 13: 2401-2407, 1995.
2. Deutsch M, Dourakis S, Manesis EK, et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alpha therapy. Hepatology 26: 206-210, 1997.
3. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. International Hepatology Communications 6: 112-119, 1996 (in Japanese).
4. Sakane N, Yoshida T, Yoshioka K, Umekawa T, Kondo M, Shimatsu A. Reversible hypopituitarism after interferon alpha therapy. Lancet 345: 1305, 1995.
5. Concha LB, Carlson HE, Heimann A, Lake-Bakaar GV, Paid AF. Interferon-induced hypopituitarism. Am J Med 114: 161-163, 2003.
6. Chan WB, Cockram CS. Panhypopituitarism in association with interferon-alpha treatment. Singapore Med J 45: 93-94, 2004.
7. Ridruejo E, Christensen AF, Mando OG. Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin. Eur J Gastroenterol Hepatol 18: 693-694, 2006.
8. Mabe K, Shinzawa H, Yamatani K, et al. Interferon induced coma in Sheehan's syndrome. J Gastroenterol Hepatol 12: 551-553, 1997.
9. Gisslinger H, Svoboda T, Clodi M, et al. Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57: 489-495, 1993.
10. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325: 1325-1329, 1991.
11. Diederich S, Franzen NF, Bahr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 148: 609-617, 2003.